Beamtree Holdings (ASX:BMT) has announced its trading and operational update for the first quarter of FY25. The company achieved a 16% increase in revenue, driven by recurring income, and saw international revenues surge by over 35%. Beamtree also reduced its operating losses and is on track to meet its FY25 growth target.
Beamtree Holdings has reported robust growth in Q1 FY25, with a 16% revenue rise fueled by recurring revenue and international expansion. The company reduced its operating loss and aims for break-even in the first half of FY25. With strategic contracts in Saudi Arabia and new product launches, Beamtree is positioned to hit its 20% revenue growth target for FY25 and achieve $60 million ARR by the end of 2026. The focus remains on expanding international markets and managing costs effectively to support its ambitious growth trajectory.
Beamtree's focus on expanding our international footprint and delivering innovative solutions in healthcare is paying off. Our disciplined approach to cost management and our strategic investments in key markets like the UK, Canada, and Saudi Arabia have contributed to our strong performance this quarter. We remain committed to achieving our growth targets and delivering value to our stakeholders.